Since 1981, when the first haemorrhagic dengue epidemic in the Americas was reported in Cuba, the country has remained dengue free, with the exception of sporadic, isolated clusters of cases ([@B14]). *Aedes aegypti* control programmes in Cuba rely on the application of the organophosphate temephos for larval control and the application of pyrethroids as adulticides. However, the widespread use of insecticides since 1981 has led to the development of resistance ([@B4]).

The sterile insect technique (SIT) ([@B18]) is a remarkably promising vector control method in terms of efficacy, efficiency and environmental compatibility. In classical SIT, the sterility of insects is induced by exposure to radiation or chemical mutagens ([@B3]).

Several alkylating agents and aziridinyl compounds have been tested as mosquito sterilants ([@B6]). Thiotepa is an alkylating agent developed in the 1950s that is being used in many chemotherapy regimens for the treatment of human solid tumours ([@B6]). The exposure of *Ae. aegypti*to thiotepa induces irreversible sterility ([@B27]).

There are concerns over the use of alkylating agents, including the safety of those handling the chemicals during sterilisation and the potential for residues remaining on released adults that could affect the environment ([@B5]). The risk of environmental contamination with the sterilising agent from the release of mosquitoes exposed in the pupal stage is very low because the amount of the thiotepa residue detected in adults is negligible ([@B19], [@B24], [@B25]). Furthermore, the common use of thiotepa in cancer therapy has led to the development of suitable procedures for the safe disposal of waste ([@B1]). The success of SIT in controlling the malaria vector *Anopheles albimanus* in El Salvador demonstrated the effectiveness of thiotepa as a sterilant ([@B20]), so its potential as a sterilising agent for SIT programmes should not be overlooked. The availability of an alternative method of sterilisation is particularly important because the purchase and maintenance of irradiators is becoming increasingly difficult due to security fears, especially in developing countries ([@B21]).

The performance of sterile mosquitoes following release is essential for the success of SIT ([@B6]). Somatic damage as a consequence of the sterilisation process has been well documented ([@B23]) and is known to affect the longevity ([@B22]), sexual vigour and competitiveness of sterilised male mosquitoes ([@B15]), with severity depending on the species ([@B16]).

Chemosterilants offer high levels of sterility and more competitive insects compared with irradiation ([@B9], [@B16]). Recently, we have shown that *Ae. aegypti* thiotepa-treated males could effectively reduce the reproductive capability of a target insect's population under laboratory conditions ([@B13]).

The objective of this study was to determine the efficacy of releasing thiotepa-treated males at a 2:1 or 5:1 sterile:fertile male ratio in reducing the stable target *Ae. aegypti* populations, measured through the egg hatch and adult catch rate in large indoor cages. Thiotepa was selected as the sterilant for three major reasons. First, the common use of thiotepa in the treatment of human cancer has led to the development of safe procedures for handling the chemical and waste disposal ([@B1]). Second, the treatment of *Ae. aegypti* with thiotepa at the pupal stage ensures complete and irreversible sterility ([@B27]). Third, the amount of thiotepa in adults is insignificant when the mosquitoes are treated at the pupal stage ([@B24], [@B25]). We discuss the results in relation to the potential for the application of this technique as a part of an integrated programme for vector management in Cuba.

MATERIALS AND METHODS
=====================

*Mosquitoes* - A wild-type strain of *Ae. aegypti* was used. To obtain a high genetic diversity, the strain was derived from a mixture of immature mosquitoes collected in five municipalities of Havana, Cuba. The adults were reared in 18 x 18 x 18 inch collapsible cages (BioQuip, USA) maintained at 26ºC ± 0.5ºC in 80-85% relative humidity (RH) with a photoperiod of 12:12 h (light/dark). A continuous supply of sucrose solution was provided. Female mosquitoes were given access to an anesthetised mouse and allowed to blood feed for 30 min weekly. The larvae were fed finely powdered fish food.

Sex separation was based on pupal size; *Ae. aegypti* female pupae are visibly larger than male pupae and hatch later ([@B11]). Pupae were individually removed from the rearing tray using a disposable pipette. In all cases, the mosquitoes were sexed prior to transferring them to the large cages.

*Sterilisation* - A 0.6% solution of thiotepa (Sigma, Belgium) was prepared in distilled water buffered to pH 8.6. Young male pupae (1-4 h old) were immersed in this solution for 6 h, rinsed twice in dechlorinated water and transferred to a Mosquito Breeder (BioQuip) for emergence. Because both fertile and sterile males were needed for each 'release' in the suppression phase, a fraction of the male pupae was treated with thiotepa.

*Large cages* - Three identical indoor screened cages (1.46 m in width, 1.85 m in length and 2.02 m in height) were used for the suppression trial. The exterior walls, floor and ceiling were made of concrete and room dividers between cages were a fine metallic mesh in appropriate aluminium frames ([Fig. 1](#f01){ref-type="fig"}). Resting and hiding sites were provided in the form of the following household objects: cotton curtains, a chair, a table, a vase with artificial flowers and a shelf. A constant environment of 26ºC ± 2ºC, 80-85% RH and a 12:12 h light:dark photoperiod was maintained.

Fig. 1: sketch of large laboratory cages. Three identical screened cages just over 5 m3 were used. Cages were randomly assigned as follows: cage A contained fertile females and fertile males in a 1:1 ratio (control), cage B fertile females, fertile males and sterilised males in a 1:1:5 ratio and cage C fertile females, fertile males and sterilised males in a 1:1:2 ratio. The access to each cage was achieved through of sleeves. A table was located inside the cages to place animals for mosquito blood-feeding, oviposition containers, recipients with pupae to release and sugar source. CDC light traps were hung inside the cage and again accessed through sleeves.

Two treatment cages and one control cage were established as follows: cage A contained fertile females and fertile males at a 1:1 ratio (control); cage B contained fertile females, fertile males and sterilised males at a 1:1:5 ratio and cage C contained fertile females, fertile males and sterilised males at a 1:1:2 ratio.

Access to each cage was obtained through a sleeve opening through which a table could be reached where the oviposition containers, animals for blood-feeding and a constant sugar source were placed. Battery-operated CDC light traps were hung inside the cage and accessed through sleeves. Cages were randomly assigned to each treatment once a stable population had been established in all cages (the end of the pre-treatment phase).

*Target populations (pre-treatment phase)* - Stable mosquito colonies were established in each of the three cages during a 20 week pre-treatment phase. Seventy pupae of each sex were added for an initial population of 140 individuals per cage and 50 individuals of each sex per cage were added weekly.

The required number of each sex were added to a Mosquito Breeder (BioQuip) placed on the tables inside the cages and the devices were uncovered once daily to allow the emerged adult mosquitoes to escape.

Four restrained guinea pigs were placed on the table of each cage around sunrise for 30 min on alternate days as a blood-feeding source and mating stimulus. Continuous access was allowed to a sucrose source by placing sugar-water-soaked cotton pads in the cages.

Three oviposition containers consisting of glass trays (18 cm in diameter, 5 cm in height) lined with filter paper and filled with 900 mL of tap water were added to each cage. Females began to oviposit at week 4. Water and filter papers were replaced to collect eggs three times per week (Monday, Wednesday and Friday) to prevent the eggs from hatching inside the cages. The eggs were counted once a week to determine the total egg lay per week. The eggs were counted under a dissecting microscope and the total oviposition was recorded by week. The eggs were allowed to mature on the moist paper strips for seven days and were then immersed in tap water at 36ºC. The resulting larvae were fed to pupation.

The hatch rate was calculated as described by [@B2]. The filter papers with eggs were recovered from the hatching trays and were examined under a stereoscope. Typically, the operculum of hatched eggs are somewhat dislodged. The hatch rate was assessed by the following formula: (number of hatched eggs/total number of eggs) x 100.

The adult populations were monitored weekly from week 2 using CDC light traps turned on at 08:00 am every Monday; at this time, the rooms were kept in the dark for 10 min. Thereafter, the room light was turned on and the traps were quickly removed from the cages, while being kept operational to prevent mosquitoes escaping. The collected mosquitoes were gently removed by a manual aspirator, counted by sex and returned to their respective cages. The adult mortality rate associated with the trapping and manipulation was 2.5%.

The end of the pre-treatment phase was determined by the observation of a stable baseline population for three consecutive weeks in all cages.

*Suppression phase* - Throughout the suppression phase, pupae were added to each cage each week to maintain the population in addition to the sterile males that were added to the treatment cages to simulate releases in an SIT programme. Each week, 50 male and 50 female pupae were added to the control cage. The number of pupae added to each treatment cage during the suppression phase was adjusted to reflect the impact of the thiotepa-treated males on the egg quantity and fertility. The percentage of female pupae added back to the control cage was calculated from the number of fertile eggs laid (total number of eggs laid multiplied by hatch rate). For example, 6,254 eggs were laid in the control cage (A) in week 25, of which 64.3% hatched, yielding 3,939 fertile eggs laid in total; thus, the 50 female pupae represented 1.26% of the total fertile eggs laid. Therefore, 1.26% of the fertile eggs collected from each of the treatment cages were added back that week in the form of female pupae and the same number of fertile male pupae, rounded down, were also added. Then, a sufficient number of sterile (thiotepa-treated) male pupae was added back to achieve a 5:1 and 2:1 ratio (sterile male:fertile male) in treatment cages B and C, respectively. For example, on week 25, 20 female pupae were added to cage B (1.26% of the 1,633 fertile eggs collected from the cage that week) and therefore, 100 sterile males and 20 fertile males were also added. Thus, the "release ratio" (sterile males released:existing male population) in the treatment cages remained constant throughout the suppression phase and the relative population sizes were maintained by the addition of female and fertile male pupae as a proportion of the number of fertile eggs collected.

*Ethics* - This study was carried out according to the principles expressed in the Declaration of Helsinki. The protocols were approved by the Institutional Research Ethical Committee at the Institute of Tropical Medicine Pedro Kourí (certificate \#54966). The permission for the use of guinea pigs was obtained from the institutional ethical committee after demonstrating that all measures were taken to avoid unnecessary suffering and severe damage to the animals.

RESULTS
=======

This study aimed to determine the efficacy of thiotepa-treated males to eradicate stable cage populations of *Ae. aegypti*when introduced into these populations at the pupal stage at 5:1 and 2:1 ratios relative to the fertile male populations. Target populations were established in three identical laboratory cages just over 5 m^3^ in volume by adding 50 male and 50 female pupae weekly to an initial population of 140 individuals. After an initial drop in the hatch rate between weeks 4 (the 1st week of oviposition) and 7, the hatch rate stabilised at approximately 65-70% and remained stable with only minor fluctuations until the suppression phase was initiated at week 20 ([Fig. 2](#f02){ref-type="fig"}). The weekly adult catch rate (number of adult females caught in a 10 min trapping session) rose rapidly from approximately five per cage in week 2 to approximately 20 per cage by week 8, after which time it stabilised in all cages ([Fig. 3](#f03){ref-type="fig"}). The total egg production and eggs laid per female per week followed the same pattern as the egg hatch rate (data not shown). One of these stable populations was randomly assigned as a control cage and the others were used as treatment cages with two or five sterile male pupae added weekly for each fertile male pupa.

Fig. 2: hatch rate of *Aedes aegypti*in treatment and control cages. Stable hatch rate was achieved in each of the three cages during a pre-treatment phase. Vertical arrow represents the start of the release of thiotepa-treated mosquitoes into the cages B and C.

Fig. 3: female catch rate. Number of adult females caught weekly in a 10 min trapping session with CDC light traps. Stable mosquito colonies were established in each of the three cages during a pre-treatment phase. Vertical arrow represents the start of the release of thiotepa-treated mosquitoes into the cages B and C.

In the control cage, the weekly introductions of 50 males and 50 females continued throughout the experiment and the reproductive parameters remained stable throughout the experiment. In the cage in which two sterile male pupae were introduced for every fertile male pupae reintroduced into the cage, which were set at a proportion equal to the proportion of fertile eggs added to the control cage each week, the hatch rate declined gradually for the first 10 weeks after the start of the suppression phase ([Fig. 2](#f02){ref-type="fig"}). After this time, the hatch rate stabilised at approximately 45%, compared to a rate of approximately 65% in the control cage. The adult catch rate did not respond to the releases until approximately five weeks into the suppression phase, after which time there was a small reduction in the adult catches in the 2:1 release cage, which stabilised at approximately 15 adults caught per trapping session compared to approximately 20 in the control cage ([Fig. 3](#f03){ref-type="fig"}).

When five sterile males were added for each fertile male, however, the effect of sterile "releases" on the cage population was more marked. After only two weeks of suppression, the hatch rate had already begun to fall noticeably and by the fifth week of release, the egg hatch rate was reduced by a third ([Fig. 2](#f02){ref-type="fig"}). This rapid decline continued until 15 weeks after the first release when no eggs collected from this cage hatched; three consecutive weeks of a 0% hatch rate were recorded before the experiment was stopped as elimination was deemed to have been achieved. The effect on the adult catch rate again took longer, but by 15 weeks into the suppression phase, the adult catch had fallen to only one adult per trapping session in the 5:1 release cage ([Fig. 3](#f03){ref-type="fig"}), reaching and remaining at zero after 13 weeks of suppression.

The eggs laid per female per week remained fairly stable at 15-20 throughout the suppression phase. Some fluctuation in the 5:1 release cage (data not shown), likely caused by the very low number of eggs collected towards the end of the experiment. Total egg production followed a similar pattern as hatch rate and adult catch rate in the treatment cages, though never reached zero (data not shown). Population eradication was thus achieved with a 5:1, but not a 2:1 release of thiotepa-treated males.

DISCUSSION
==========

The weekly release of thiotepa-sterilised males at a 5:1 ratio with the fertile males was shown to be sufficient to eradicate a large cage population of *Ae. aegypti* in 15 weeks, whereas eradication was not achieved with a 2:1 release ratio. The introduction of thiotepa-treated males continued until the 5:1 release ratio treatment cage had produced no fertile eggs for three weeks, at which time the experiment was ended. When the experiment was terminated, the hatch rate in the cage where sterile males were released at a 2:1 ratio exceeded 40% and the egg hatch and adult population (measured by adult catch during weekly trapping sessions) appeared to have stabilised by 10 weeks after the start of the suppression phase.

In applying the SIT to a target area, efficiency could be maximised by following the procedure described in this experiment and monitoring the hatch rate of eggs collected in the target area while releasing sterile males in a constant ratio to the wild male population. In this way, fewer males would need to be reared and released over time as the wild population is reduced. This might be desirable because the rearing capacity could then be used to target a second site for population suppression. Alternatively, the programme could release a constant number of sterile males so that as the programme progressed and the wild male population fell, the release ratio and thus the effectiveness of the releases would increase. This approach might be particularly suitable in an area where the immigration of mosquitoes from outside the target area is expected to be a problem, although the costs would be greater.

We have shown that the sterilisation of males with thiotepa and the release of these sterile pupae is an effective strategy for suppressing *Ae. aegypti*populations and can cause elimination of a target population in 15 weeks at a release ratio of 5:1; this length of time and scale of release is feasible in the setting of an SIT programme. Although further replicates would be desirable, this was not possible due to practical limitations and the results of this experiment are sufficiently reassuring regarding the performance of thiotepa-treated males to warrant moving directly to larger, more naturalistic suppression trials. There are, however, some limitations in laboratory experiments of this kind, even in large cages that have been modified to be similar to conditions found within a human dwelling where *Ae. aegypti*might be found resting given their propensity for using breeding sites close to human habitation in Cuba ([@B8]).

In a natural setting, the immigration of fertile insects and the emergence of fertile adults from breeding sites within the target area would make elimination more challenging; the immigration of fertilised females from outside the target site has been implicated in the failure of *Culex quinquefasciatus*and *Ae. aegypti*elimination using chemosterilised males in New Delhi in 1971 ([@B6]). The effect of adult immigration could be minimised by releasing sterile males into a buffer zone around the target suppression site or by successively controlling the mosquito population in zones in a sweeping pattern of releases ([@B6]). The effect of adults emerging from existing eggs laid in the trial site, a particular problem in *Aedes*spp whose eggs are resistant to desiccation, could be minimised by breeding site reduction prior to release.

There is the possibility that the competitiveness of the sterilised males could be impaired relative to that measured in laboratory trials by the less controlled and most likely harsher conditions found in the open field. In one recent example of such an effect, a transgenic line of *Ae. aegypti*was shown to be able to suppress stable laboratory populations through weekly releases of effectively sterile males within 10-20 weeks (de [@B7]), but this same strain failed to achieve elimination in large outdoor field cages in southern Mexico with 17 weeks of releases ([@B10]).

Finally, the density of adult mosquitoes in the cages at the end of the trial was unrealistically high compared to the population densities that are likely to be found in nature. For example, a study in Guasave Sinaloa, Mexico, measured an adult density index of approximately three *Ae. aegypti*adults per premises ([@B12]) and work in a Vietnamese village found a female adult abundance of between one-43 individuals per house ([@B17]). However, it is not practicable to maintain a stable population at these low densities in artificial conditions and a larger cage population allows for a more effective demonstration of the effectiveness of sterile "releases".

However, these results are valuable because they show that SIT using thiotepa sterilisation is a promising technique and that further exploration of the technique and testing on a larger and more natural scale would be worthwhile. Any gross reduction in the performance of sterilised males would likely have become apparent during the course of this trial, making elimination at a 5:1 ratio impossible. A five-to-one release ratio is relatively low, which is a promising sign for the success of an SIT programme using thiotepa sterilisation. The sterile males seem to have successfully competed for mates with the untreated males, as evidenced by the increased number of sterile eggs laid in the treatment cages relative to the control over time. Any impact on male performance caused by the mutagenic action of thiotepa is expected to be fairly minimal and if a modest reduction in competitiveness becomes apparent in more stringent testing, this could be overcome with an increased release ratio.

The present study is a significant step in addressing the gaps in the knowledge related to the inclusion of SIT as a practical part of integrated vector management for dengue control. Field trials to assess the effectiveness of the technology for application in Cuba will require the establishment of public confidence and the gathering of extensive resources and labour. However, although additional studies are required to guarantee the safety and efficacy of thiotepa as a sterilising method for mosquito releases, the success of the sterile mosquitoes in suppressing target cage populations in this study is likely to help gain acceptance for this method and other technologies based on SIT.
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